Skip to content

Impact of Physical Therapy Intervention on Foot and Ankle Function

Impact of Physical Therapy Intervention on Foot and Ankle Function in Children and Adolescents With Non-CNS Cancers

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04930406
Enrollment
80
Registered
2021-06-18
Start date
2012-12-18
Completion date
2024-12-31
Last updated
2024-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasms, Physical Therapy Modalities, Survivorship

Brief summary

This research study will investigate the effect of physical therapy intervention on the function of the foot and ankle in children and adolescents with cancer not involving the brain or spinal cord. Children undergoing treatment for cancer can suffer from decreased flexibility, strength, balance and endurance from the cancer and from direct effects of the chemotherapy agents. These deficits have been shown to continue years after treatment end with adult survivors of cancer being less physically active then their siblings. Children, whose chemotherapy includes neurotoxic agents such as vincristine, can develop damage to their peripheral nervous system affecting the strength, sensation, and flexibility in their hands and feet. This can then lead to a change in their walking pattern and likely contributes to decreased physical activity level and fatigue. The principal investigator is currently involved in research with Dr. Laura Gilchrist and Dr. Mary C. Hooke establishing the reliability and validity of a measurement tool to quantify peripheral neuropathy, identifying physical impairments of children with cancer during treatment, and comparing physical performance in children after treatment completion with and without physical therapy intervention. The principal investigator is also completing data analysis on a pilot study investigating the use of ankle foot orthotics in children and adolescents with non-CNS cancer. In this study, the investigators will further the research by measuring the effect of physical therapy intervention on measurements involving the function and structure of the ankle and foot. The investigators will compare participants who have and have not received physical therapy intervention during cancer treatment by administering measurements detailing the function of the foot and ankle in order to further evaluate the benefit of physical therapy for children with cancer. Physical therapy intervention involving children and adolescents with cancer focuses on minimizing the physical impairments caused by chemotherapy and radiation treatment, as well as promoting normal development of motor skills typically obtained by a child in their age group. In the oncology population, physical therapy often targets the foot and ankle as this is most affected by peripheral neuropathy. Interventions include strengthening, balance training, stretching, and orthotic use to allow normal motor skills. Families are instructed in exercises that can be completed at home to further improve their function. This study will examine the difference in the function of the foot and ankle years after intervention in participants who have and have not received these interventions. The investigators will measure neuropathy, ankle flexibility, ankle strength, foot posture, gait mechanics, and endurance in order to fully examine the foot and ankle as well as evaluate relationships between the variables in long-term survivors of pediatric cancer.

Interventions

OTHERPhysical therapy

Had to receive 10 or more visits of physical therapy during the cancer treatment period to qualify for intervention group.

Sponsors

Children's Hospitals and Clinics of Minnesota
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
7 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Historical control group * Children and adolescents age 7-30 * English speaking family * Diagnosed with a non-CNS cancer diagnosis with chemotherapy regimen including vincristine, carboplatin, or cisplatin * Completed cancer treatment greater than 5 years ago * Received less than 2 intervention visits of outpatient physical therapy during cancer treatment -• Intervention group * Children and adolescents age 7-30 * English speaking family * Completed cancer treatment greater than 5 years ago * Greater than 10 physical therapy visits at Children's Hospitals and Clinics of MN * Received PT evaluation within 6 months of starting cancer treatment.

Exclusion criteria

* • Neurological impairments prior to cancer diagnosis * Developmental disorders (Downs syndrome, chromosomal disorders) * Non-English speaking parent/child * Lower extremity or pelvic surgery

Design outcomes

Primary

MeasureTime frameDescription
Ankle range of motionOne day studyActive and passive ankle range of motion measured by goniometry
Ankle strengthOne day studyAnkle plantarflexion and dorsiflexion dynamometry and manual muscle testing of ankle dorsiflexion and great toe extension

Secondary

MeasureTime frameDescription
Gait capacityOne day study6-minute walk test
GaitOne day studySpatiotemporal parameters of gait measured by Gaitrite system
Chemotherapy-induced peripheral neuropathyOne day studyCIPN measured by the Pediatric Modified Total Neuropathy Scale. Scores range from 0 - 32 with higher scores correlating to greater severity in neuropathy. Cut-off score for clinical neuropathy is 4.
BalanceOne day studyBruininks-Oseretsky Test of Motor Proficiency balance subtest
Faces pain scale and visual analog scaleOne day studyFaces pain scale and visual analog scale with scores ranging from 0-10 with higher numbers indicating greater pain level.
Running speedOne day studyPresidential fitness shuttle run
Foot postureOne day studyStanding hindfoot alignment

Countries

United States

Contacts

Primary ContactLynn R Tanner, PT
lynn.tanner@childrensmn.org612-813-6274
Backup ContactChristine Hajduk, BA
christine.hajduk@childrensmn.org612-813-6744

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026